Q1 2023 13F Holders as of 31 Mar 2023
-
Type / Class
-
Equity / Common Stock, $0.01 par value
-
Shares outstanding
-
127,085,490
-
Total 13F shares
-
53,442,433
-
Share change
-
-2,225,417
-
Total reported value
-
$113,798,804
-
Put/Call ratio
-
1771%
-
Price per share
-
$2.13
-
Number of holders
-
130
-
Value change
-
-$5,356,219
-
Number of buys
-
68
-
Number of sells
-
76
Institutional Holders of Organogenesis Holdings Inc. - Common Stock, $0.01 par value (ORGO) as of Q1 2023
As of 31 Mar 2023,
Organogenesis Holdings Inc. - Common Stock, $0.01 par value (ORGO) was held by
130 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
53,442,433 shares.
The largest 10 holders included
Soleus Capital Management, L.P., BlackRock Inc., VANGUARD GROUP INC, AQR CAPITAL MANAGEMENT LLC, CITADEL ADVISORS LLC, FEDERATED HERMES, INC., MILLENNIUM MANAGEMENT LLC, GEODE CAPITAL MANAGEMENT, LLC, ACADIAN ASSET MANAGEMENT LLC, and Assenagon Asset Management S.A..
This page lists
130
institutional shareholders reporting positions in this security
for the Q1 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.